IP Library › Assignment 073538/0532
Patent Assignment
Reel/Frame 073538/0532

Merger

Recorded: 2026-01-21 Pages: 6
Assignor
Assignee
CHANNEL THERAPEUTICS CORPORATION
4400 ROUTE 9 SOUTH, SUITE 1000, FREEHOLD, NEW JERSEY, 07728
Covered Property (1)
Sodium Channel Modulators for the Treatment of Pain and Diabetes
Patent: 9,458,118 →
Application: 14/994,846 →
Publication: US 2016/0130239
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 6, 2016
From: BABICH, OLGA; GARYANTES, TINA; LUO, ROBERT Z.; PALLING, DAVID J.
To: CHROMOCELL CORPORATION
Reel/Frame 040538/0290 →
Security Interest Oct 10, 2023
From: CHROMOCELL THERAPEUTICS CORPORATION
To: BALMORAL FINANCIAL GROUP LLC
Reel/Frame 065171/0575 →
Security Interest Oct 10, 2023
From: CHROMOCELL THERAPEUTICS CORPORATION
To: BALMORAL FINANCIAL GROUP LLC
Reel/Frame 065171/0716 →
Assignment of Assignor's Interest Jan 21, 2026
From: CHROMOCELL CORPORATION
To: CHROMOCELL THERAPEUTICS CORPORATION
Reel/Frame 073538/0496 →
Assignment of Assignor's Interest Jan 21, 2026
From: CHANNEL THERAPEUTICS CORPORATION
To: CHANNEL PHARMACEUTICAL CORPORATION
Reel/Frame 073538/0538 →
Security Interest Jan 30, 2026
From: CHANNEL PHARMACEUTICAL CORPORATION; PELTHOS THERAPEUTICS INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 073644/0472 →